Insulin aspart/insulin aspart protamine

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus

Manufacturer:

Novo Nordisk Canada Inc.

Brand Name:

NovoMix 30

Project Line:

Reimbursement Review

Project Number:

SR0041-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus

Recommendation Type:

Do not list

Final Recommendation:

April 26, 2006

Recommendation:

(tentative) Reconsideration requested. Reconsideration on April 19, 2006

Last Updated : October 13, 2005